Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Plant scientists in Norwich lead 11.8 million euro study of RNA silencing to treat life-threatening diseases.

19.04.2007
Scientists in Norwich are leading a new research consortium to study how RNA silencing could be used to treat life-threatening diseases.

The European Commission has committed 11.8 million euros to this four-year Integrated Project funded under the Sixth Framework Programme.

“RNA silencing, also called RNA interference, is the cell’s natural ability to turn off genes”, said Professor David Baulcombe of the Sainsbury Laboratory at the John Innes Centre. “Only a few years ago it was unknown, but now RNA silencing is one of the most powerful tools available to researchers. We can use it to understand the function of genes and the mechanisms of cellular regulation. We can also use it as a diagnostic tool for cancer and other diseases. In future it may also be possible to use RNA silencing as the basis of novel therapy for diverse diseases ranging from avian influenza to cancer.”

RNA silencing is thought to have evolved as a defence mechanism against viruses. In primitive cells it was a type of immune system that could recognize and then silence viral genes. Later in evolution the silencing mechanism was recruited for switching off genes involved in normal growth of cells and responses to stress. It occurs in all sorts of organisms from yeasts to humans and the recent discoveries have revealed a previously unknown role for RNA (ribonucleic acid). They have shown how, in addition to the previously understood role as a cellular messenger that directs protein synthesis, RNA can also silence expression of genes. By introducing specific silencing RNAs into an organism, the expression of genes can be turned down in a controlled way.

“Although there has been rapid recent progress in understanding RNA silencing there is still much to be done” said Professor Baulcombe. “For example we need to ensure that an RNA targeted against gene X will only silence gene X and nothing else. When we can do that we will be able to use RNA as a drug without side effects. We also need to understand more about the role of silencing RNAs in normal growth and development. That information will then allow us to use the presence of silencing RNAs to diagnose disease states in a cell.”

Stimulated by the great potential of RNA silencing the European Commission has funded a consortium of the leading European laboratories. The consortium includes researchers working on RNA silencing in model plant and animal systems as well as humans. The use of the model systems allows experiments to be carried out that would be impossible with humans although the new discoveries may be translatable into new technologies for use in medicine.

Seventeen world-class laboratories and companies from nine European countries are members of the SIROCCO consortium. SIROCCO stands for “Silencing RNAs: organisers and coordinators of complexity in eurkaryotic organisms”.

Dr Aileen Hogan | alfa
Further information:
http://www.sainsbury-laboratory.ac.uk

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>